Skip to content

Communication, Coordination und Security for People with Multiple Sclerosis

Communication, Coordination und Security for People with Multiple Sclerosis - COCOS-MS

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00022771
Enrollment
80
Registered
2021-01-11
Start date
2021-01-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregivers G35

Interventions

Group 1: In the intervention arm, MS patients and their caregivers will receive standard care within the existing health and social structures and an additional social advocacy CCM service that will p

Sponsors

Universität zu Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with: 1) Highly active MS with an indication for an escalating immunotherapeutic agent and being treated with such, and at least one of the following: age = 50, expanded disability status scale (EDSS) = 5 (Subgroup 1) 2a) Primary or secondary chronic progressive MS, age = 18, EDSS 4-7, no immunotherapeutic treatment options (Subgroup 2a) 2b) Primary or secondary chronic progressive MS, age = 18, EDSS > 7 (Subgroup 2b) AND - residence in the administrative district of Cologne AND one of the following criteria applies: - full command in understanding, reading, responding of German language skills and ability to give written informed consent - if a patient is unable to give consent, a legal representative with a full command of the German language (understanding, reading, responding) and is able to give written informed consent can act on behalf of the patient Caregivers: - age = 18 - responsible for caring for the patient - full command of the German language (understanding, reading, responding) - ability to give written informed consent

Exclusion criteria

Exclusion criteria: - lack of consent to follow protocol - current drug abuse, alcohol abuse or psychiatric illness, which, in the opinion of the trial physician obtaining informed consent, renders the patient or caregiver unfit for participation - any kind of dependency on the PCI or sponsor (including being employed there) - legal incapacity (caregivers only)

Design outcomes

Primary

MeasureTime frame
Patients' quality of life measured by the "HALEMS", which will be collected every three months.

Secondary

MeasureTime frame
- Patients’ risk perception (self-designed risk perception questionnaire), palliative care needs (Integrated Palliative care Outcome Scale (IPOS) / Short Form Integrated Palliative care Outcome Scale for neurological conditions (8-item version) (IPOS Neuro-S8)), anxiety and depression (Hospital Anxiety and Depression Scale (HADS)), use of health care services (self-designed cost booklet) - Caregivers’ burden (Short Form Zarit Burden Interview (12-item version) (ZBI-12)) and quality of life (Short Form Health Survey (12-item version) (SF-12)) - Meeting patients’ and caregivers’ needs (part of self-designed CCM manual) This data will be collected every three months. The CCM manual will also be used in a short form for the weekly telephone calls.

Countries

Germany

Contacts

Public ContactVeronika Dunkl

Zentrum für Palliativmedizin

veronika.dunkl@uk-koeln.de0221/478-85910

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 16, 2026